Basics Atea Pharmaceuticals, Inc. IPO Date: October 30, 2020 Sector: Healthcare Industry: Biotech Market Cap: $247.66M Activated in VL: True Average Daily Range Avg Daily Range: $0.40 | 2.66% Avg Daily Range (30 D): $0.05 | 1.64% Avg Daily Range (90 D): $0.06 | 1.84% Institutional Daily Volume Avg Daily Volume: .68M Avg Daily Volume (30 D): .35M Avg Daily Volume (90 D): .3M Trade Size Avg Trade Size (Sh.): 117 Avg Trade Size (Sh.) (30 D): 99 Avg Trade Size (Sh.) (90 D): 96 Institutional Trades Total Inst.Trades: 745 Avg Inst. Trade: $1.95M Avg Inst. Trade (30 D): $.83M Avg Inst. Trade (90 D): $.82M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.57M Avg Closing Trade (30 D): $.99M Avg Closing Trade (90 D): $.99M Avg Closing Volume: 183.51K     News Nov 7, 2025 @ 1:00 PM Atea Pharmaceuticals Presents New Data Supporting ... Source: Atea Pharmaceuticals Nov 5, 2025 @ 12:00 PM Atea Pharmaceuticals to Host Third Quarter 2025 Fi... Source: Jonae Barnes Jul 31, 2025 @ 11:00 AM Atea Pharmaceuticals to Host Second Quarter 2025 F... Source: Atea Pharmaceuticals Jun 24, 2025 @ 11:00 AM Atea Pharmaceuticals Announces Continued Advanceme... Source: N/A Apr 23, 2025 @ 11:00 AM Atea Pharmaceuticals to Present New Data Showcasin... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.53 $-.44 $-.4 Diluted EPS $-.53 $-.44 $-.4 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -42.05M $ -37.16M $ -34.27M Operating Income / Loss $ -45.57M $ -41.35M $ -39.04M Cost of Revenue $ $ $ Net Cash Flow $ -10.38M $ -31.67M $ 54.7M PE Ratio     Splits Feb 14, 2018:   1:11